@article{article, title  = {{Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues}},

 publisher = {{Dove Medical Press}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/107903 http://dx.doi.org/10.2147/DDDT.S84177 }},

 year = {{2015}},

 month = {{9}},

 author = {{Wolin EM and Jarzab B and Eriksson B and Walter T and Toumpanakis C and Morse MA and Tomassetti P and Weber MM and Fogelman DR and Ramage J and Poon D et al}},

 doi = {{10.2147/DDDT.S84177}},

 volume = {{9}},

 journal = {{Drug Design, Development and Therapy}},

 pages = {{5075-5086}},

 note = {{Accessed on 2025/11/05}}}